Morning-after pill may not work in heavier women

January 24, 2014

The European Medicines Agency says it has started a review of emergency contraceptives to see if they work less well in heavier women.

In November, French drug maker HRA Pharma announced its morning-after pill Norlevo was less effective in weighing more than 75 kilograms (165 pounds) and that it didn't work for women more than 80 kilograms (176 pounds). HRA Pharma changed its labels to warn patients after consulting with European regulators.

In a statement on Friday, the EMA said it would evaluate new data suggesting that a high body weight could compromise the effectiveness of the morning-after pill.

"This is an efficacy issue," said Monika Benstetter, an agency spokeswoman. "We need to find out what the association is with () and if there is a cut-off threshold for when the medicine becomes less effective."

HRA Pharma's Norlevo contains levonorgestrel, the same active ingredient in other medicines including ellaOne, Levonnelle and Levodonna. One of the studies that prompted the label change on Norlevo found the risk of emergency contraception failing was higher in women with a body mass index higher than 25, considered to be overweight.

EMA's Benstetter said the agency needed to perform an assessment of all products in the same category as Norlevo to ensure labels across the European Union are consistent. She said there was no timeline on when the review would be completed.

In November, the U.S. Food and Drug Administration said it was also studying the issue.

The morning-after pill can be taken up to 72 hours after unprotected sex. It contains a higher dose of the hormone in regular and works by preventing ovulation or fertilization of an egg. It has no effect if a woman is already pregnant.

Some doctors have previously advised that heavy women consider alternatives like a copper IUD, a birth control device that can be fitted on the uterus.

Explore further: French drugmaker warns on morning-after pill (Update)

Related Stories

French drugmaker warns on morning-after pill (Update)

November 26, 2013
A French contraceptive maker said Tuesday its morning-after pill doesn't work when taken by women who weigh more than 80 kilograms (176 pounds) and plans to change its labels to warn patients.

EU drug agency rejects French request on birth pills

October 11, 2013
The European Medicines Agency (EMA) on Friday rejected a French request to tighten prescription guidelines on types of birth-control pills linked with a relatively higher risk of blood clots.

EU drug agency to review safety of new-generation Pill (Update)

January 28, 2013
The European Medicines Agency (EMA) on Monday said it would review safety data for third- and fourth-generation birth control pills, responding to French concern that these contraceptives may cause dangerous blood clots.

Recommended for you

Mind-body therapies immediately reduce unmanageable pain in hospital patients

July 25, 2017
Mindfulness training and hypnotic suggestion significantly reduced acute pain experienced by hospital patients, according to a new study published in the Journal of General Internal Medicine.

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.